Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 17, 2014 08:30 ET | Source: Biocept, Inc.

Biocept's Patented Platform Identifies Clinically HER2-Negative Patients With HER2-Positive Circulating Tumor Cells

SAN DIEGO, Dec. 17, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor cells (CTCs) and circulating...
December 15, 2014 08:30 ET | Source: Biocept, Inc.

Biocept Expands Worldwide Microchannel Patent Protection to South Korea

SAN DIEGO, Dec. 15, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA)...
December 03, 2014 08:30 ET | Source: Biocept, Inc.

Biocept Appoints Experienced Physician as Medical Director

SAN DIEGO, Dec. 3, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA)...
November 13, 2014 16:05 ET | Source: Biocept, Inc.

Biocept Reports Third Quarter 2014 Financial Results

SAN DIEGO, Nov. 13, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA)...
November 12, 2014 08:30 ET | Source: Biocept, Inc.

Biocept Launches Lung Cancer Offering

SAN DIEGO, Nov. 12, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor DNA and Circulating Tumor...
November 06, 2014 08:30 ET | Source: Biocept, Inc.

Biocept, Inc. Schedules Webcast and Conference Call for Third Quarter 2014 Financial Results

SAN DIEGO, Nov. 6, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA (cfDNA) and...
October 13, 2014 08:30 ET | Source: Biocept, Inc.

Biocept and Rosetta Genomics Collaborate to Evaluate microRNAs From Circulating Tumor Cells

SAN DIEGO and PRINCETON, N.J. and REHOVOT, Israel, Oct. 13, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of...
October 07, 2014 08:30 ET | Source: Biocept, Inc.

Biocept Expands Collaboration With MD Anderson Cancer Center

SAN DIEGO, Oct. 7, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA and circulating...
September 30, 2014 08:30 ET | Source: Biocept, Inc.

Biocept to Present at the 13th Annual BIO Investor Forum

SAN DIEGO, Sept. 30, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis in circulating tumor cell (CTC) and circulating...
September 18, 2014 08:30 ET | Source: Biocept, Inc.

Biocept Granted Patent in China for Its Microfluidic Channel Technology Used to Capture Circulating Tumor Cells

SAN DIEGO, Sept. 18, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA)...